S032 Pearls from the Masters of Dermatological Surgery
DESCRIPTION
This fast-moving session is highly popular with attendees and speakers. Each speaker will present 1-3 pearls and has been selected for their experience and teaching reputation in dermatologic oncology/laser surgery or cosmetic dermatology. The pearls are all designed to be immediately relevant to clinical practice. Please join us for this highly practical and interactive session. This activity has been approved by the American Board of Dermatology (ABD) for up to 30 Continuous Certification Program (CCP) Component 2 Self-Assessment points. For more information about CCP, please visit the ABD website at www.abderm.org.
LEARNING OBJECTIVES
Demonstrate new concepts in dermatologic oncology and cosmetic dermatology.
Define the subtleties of toxins, fillers and devices.
Describe new surgical repairs and solutions for dermatologic problems in clinical practice.
SCHEDULE
9:00 AM
Introduction
C. William Hanke, MD, FAAD
9:05 AM
Dr. Moody's Pearls
Brent R. Moody, MD, FAAD
9:15 AM
Dr. Rokhsar's Pearls
Cameron K. Rokhsar, MD, FAAD
9:25 AM
Dr. Wambier's Pearls
Carlos G Wambier, MD, IFAAD
9:35 AM
Dr. Shamban's Pearls
Ava T. Shamban, MD, FAAD
9:45 AM
Dr. Rossi's Pearls
Anthony Rossi, MD, FAAD
9:55 AM
Dr. Waibel's Pearls
Jill S. Waibel, MD, FAAD
10:05 AM
Dr. Tolkachjov's Pearls
Stanislav Nickolaevich Tolkachjov, MD, FAAD
10:15 AM
Dr. Butterwick's Pearls
Kimberly J. Butterwick, MD, FAAD
10:25 AM
Dr. Bernstein's Pearls
Eric F. Bernstein, MD, FAAD
10:35 AM
Dr. Cox's Pearls
Sue Ellen Cox, MD, FAAD
10:45 AM
Dr. Carucci's Pearls
John A. Carucci, MD, PhD
10:55 AM
Dr. Day's Pearls
Doris J. Day, MD, FAAD
11:05 AM
Dr. Rohrer's Pearls
Thomas E. Rohrer, MD, FAAD
11:15 AM
Dr. Hanke's Pearls
C. William Hanke, MD, FAAD
11:25 AM
Dr. Ratner's Pearls
Desiree Ratner, MD, FAAD
11:35 AM
Dr. Donofrio's Pearls
Lisa M. Donofrio, MD, FAAD
11:45 AM
Dr. Kossintseva's Pearls
Iren Kossintseva, MD, FAAD
DIRECTOR
C. William Hanke, MD, FAAD
SPEAKERS
Eric F. Bernstein, MD, FAAD
Kimberly J. Butterwick, MD, FAAD
John A. Carucci, MD, PhD
Sue Ellen Cox, MD, FAAD
Doris J. Day, MD, FAAD
Lisa M. Donofrio, MD, FAAD
Iren Kossintseva, MD, FAAD
Brent R. Moody, MD, FAAD
Desiree Ratner, MD, FAAD
Thomas E. Rohrer, MD, FAAD
Cameron K. Rokhsar, MD, FAAD
Anthony Rossi, MD, FAAD
Ava T. Shamban, MD, FAAD
Stanislav Nickolaevich Tolkachjov, MD, FAAD
Jill S. Waibel, MD, FAAD
Carlos G Wambier, MD, IFAAD
DISCLOSURES
Eric F. Bernstein, MD, FAAD
Acclaro Medical – Founder(Stock Options), Investigator(Equipment), Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Stock Options), Investigator(Grants/Research Funding); Joylux – Advisory Board(Stock Options); Novoxel – Advisory Board(Stock Options); Remedly, Inc – Advisory Board(Stock Options);
Kimberly J. Butterwick, MD, FAAD
Allergan, Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Evolus, Inc. – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria); Merz Pharmaceuticals, LLC – Advisory Board(Honoraria); Neutrogena Corporation – Advisory Board(Honoraria); Rapalogix Health – Stockholder Private Company(Stock); Revance Therapeutics, Inc. – Advisory Board(Honoraria);
John A. Carucci, MD, PhD
Regeneron – Investigator(Grants/Research Funding);
Sue Ellen Cox, MD, FAAD
Allergan, Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Caliway Biopharmaceuticals Co., Ltd – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Candesant Biomedical, Inc. – Stockholder(Stock); Cearna, Inc – Consultant(Fees); Croma-Pharma GmbH Austria – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Evolus, Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Consultant(Fees), Investigator(Grants/Research Funding); Galderma Laboratories, LP – Advisory Board(Honoraria); Hugel – Advisory Board(Honoraria); Ipsen – Investigator(Grants/Research Funding); Jetema – Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding), Stockholder(Stock); Rion Aesthetics – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Suneva Medical, Inc. – Advisory Board(Honoraria); TEOXANE Laboratories – Consultant(Fees), Investigator(Grants/Research Funding); TruInject Medical Corporation – Advisory Board(No Compensation Received);
Doris J. Day, MD, FAAD
Allergan, Inc – Advisory Board(Honoraria); Crown Laboratories, Inc. – Advisory Board(Honoraria); Fotona, LLC – Speaker(Honoraria); Galderma USA – Advisory Board(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); La Roche-Posay Laboratoire Pharmaceutique – Advisory Board(Honoraria); Merz Aesthetics – Advisory Board(Honoraria); Regimen MD – Stockholder(Stock Options); Revance Therapeutics, Inc. – Stockholder(Stock Options);
Lisa M. Donofrio, MD, FAAD
Allergan, Inc. – Investigator(Other Financial Benefit); Galderma Laboratories, L.P. – Investigator(None Chosen); Galderma USA – Consultant(Honoraria); Journal of Dermatologic Surgery – Other(No Compensation Received);
C. William Hanke, MD, FAAD
Abbvie – Investigator(Grants/Research Funding); Biofrontera AG – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Ipsen – Investigator(Grants/Research Funding);
Iren Kossintseva, MD, FAAD
No financial relationships exist with ineligible companies.
Brent R. Moody, MD, FAAD
Castle Biosciences – Speaker(Honoraria); Regeneron – Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Advisory Board(Honoraria);
Desiree Ratner, MD, FAAD
Castle Biosciences, Inc – Speaker(Honoraria);
Thomas E. Rohrer, MD, FAAD
Acclaro Medical – Advisory Board(Fees); Candela Corporation – Advisory Board(Honoraria), Speaker(Honoraria); Lumenis – Investigator(Grants/Research Funding); UpToDate – Other(Honoraria);
Cameron K. Rokhsar, MD, FAAD
No financial relationships exist with ineligible companies.
Anthony Rossi, MD, FAAD
No financial relationships exist with ineligible companies.
Ava T. Shamban, MD, FAAD
Aesthetics Biomedical – Consultant(Honoraria); Allergan, Inc – Investigator(Grants/Research Funding), Speaker(Honoraria); Evolus, Inc. – Speaker(Honoraria); Fotona, LLC – Speaker(Honoraria); Galderma – Consultant (1099 relationship)(Honoraria); Galderma USA – Investigator(Grants/Research Funding); Hydrinity – Speaker(Honoraria); Lumisque – Consultant (1099 relationship)(Honoraria); Novaestiq Corp – Advisory Board(Honoraria); Revance Therapeutics, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Sinclair Pharma, LLC – Speaker(Honoraria); Sofwave – Speaker(Honoraria); Solta Medical – Advisory Board(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding);
Stanislav Nickolaevich Tolkachjov, MD, FAAD
Boehringer Ingelheim – Speaker(Honoraria); Castle Biosciences – Speaker(Honoraria); Disc Medicine – Speaker(Fees); Kerecis Limited – Speaker(Grants/Research Funding); Leo Pharma – Speaker(Honoraria); Natera – Speaker(Honoraria); StimLabs – Investigator(Grants/Research Funding);
Jill S. Waibel, MD, FAAD
Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); BellaMia Technologies Inc. – Advisory Board(No Compensation Received); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding), Speaker(No Compensation Received); Galderma – Consultant (1099 relationship)(No Compensation Received), Investigator(Grants/Research Funding); Johnson & Johnson Innovative Medicine – Investigator(Grants/Research Funding); Lumenis – Advisory Board(Honoraria), Consultant (1099 relationship)(No Compensation Received), Speaker(Honoraria); Neuronetics NeuroStar – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);
Carlos G Wambier, MD, IFAAD
Allergan, Inc. – Advisory Board(Fees); Applied Biology – Advisory Board(Fees); ChemistryRx – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Cynosure – Speaker/Faculty Education(Fees); Daniel Alain – Advisory Board(Fees); Eli Lilly – Investigator(Grants/Research Funding); Galderma Brasil Ltda – Speaker(Fees); Incyte – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Investigator(Grants/Research Funding); Wambier Dermatologics, LLC – Founder(Other Financial Benefit); Young Pharmaceuticals – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights);